# Sevoflurane- Safety in Long-term Sedation Procedures

> **NCT01802255** · PHASE3 · WITHDRAWN · sponsor: **F Javier Belda**

## Conditions studied

- Poisoning by Inhaled Anaesthetic
- Fluoride Poisoning
- Recovery From Sedation
- Renal Function
- Hepatic Function

## Interventions

- **DRUG:** Sevoflurane
- **DRUG:** Midazolam

## Key facts

- **NCT ID:** NCT01802255
- **Lead sponsor:** F Javier Belda
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2013-03
- **Primary completion:** 2015-01
- **Final completion:** 2015-06
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Lack of recruitment in the Centres
- **Last updated:** 2021-08-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01802255

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01802255, "Sevoflurane- Safety in Long-term Sedation Procedures". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01802255. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*